14-44505142-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032135.4(FSCB):c.1846G>A(p.Glu616Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000746 in 1,608,428 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151690Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.00000822 AC: 2AN: 243446Hom.: 0 AF XY: 0.00000750 AC XY: 1AN XY: 133298
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1456738Hom.: 0 Cov.: 34 AF XY: 0.00000414 AC XY: 3AN XY: 724716
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151690Hom.: 0 Cov.: 30 AF XY: 0.0000135 AC XY: 1AN XY: 74056
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2022 | The c.1846G>A (p.E616K) alteration is located in exon 1 (coding exon 1) of the FSCB gene. This alteration results from a G to A substitution at nucleotide position 1846, causing the glutamic acid (E) at amino acid position 616 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at